acridines has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, HW; Hong, CW; Huang, WJ; Wang, BJ; Wang, YC; Wang, YJ; Wu, YH; Yeh, YL | 1 |
| Bloch, NB; Chiorazzo, MG; Delikatny, EJ; Popov, AV | 1 |
2 other study(ies) available for acridines and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
A novel histone deacetylase inhibitor TMU-35435 enhances etoposide cytotoxicity through the proteasomal degradation of DNA-PKcs in triple-negative breast cancer.
Topics: Acridines; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Autophagy; Carrier Proteins; Cell Line, Tumor; DNA Damage; DNA End-Joining Repair; DNA-Activated Protein Kinase; DNA-Binding Proteins; Dose-Response Relationship, Drug; Drug Synergism; Etoposide; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Mice; Mice, Inbred BALB C; Mice, Nude; Nuclear Proteins; Proteasome Endopeptidase Complex; Proteolysis; Time Factors; Topoisomerase II Inhibitors; Triple Negative Breast Neoplasms; Ubiquitin-Protein Ligases; Ubiquitination | 2017 |
Synthesis and Evaluation of Cytosolic Phospholipase A(2) Activatable Fluorophores for Cancer Imaging.
Topics: Acridines; Arachidonic Acid; Cell Line, Tumor; Cytosol; Enzyme Assays; Female; Fluorescent Dyes; Humans; Optical Imaging; Phospholipases A2; Triple Negative Breast Neoplasms | 2015 |